Marimed Inc is primarily active in the cannabis industry.

The main competitors of Marimed Inc in the market include Curaleaf Holdings Inc, Green Thumb Industries Inc, Trulieve Cannabis Corp, and Cresco Labs Inc.

Marimed Inc. is a leading cannabis company with a rich history and impressive background. Established in 2011, Marimed has since emerged as a prominent player in the industry, specializing in cannabis cultivation, production, and consulting services. The company has successfully developed state-of-the-art facilities and high-quality cannabis strains, positioning itself as a trusted provider of premium cannabis products. With a focus on innovation and sustainability, Marimed continues to expand its reach and influence in the rapidly growing cannabis market. This Massachusetts-based company has gained widespread recognition for its expertise, commitment to customer satisfaction, and dedication to meeting the evolving needs of cannabis enthusiasts and patients alike.

Marimed Inc has achieved significant milestones in its journey. One notable achievement is its strong expansion in the cannabis industry, becoming a leading multi-state operator. The company has successfully established a presence in key states, including Massachusetts, Illinois, and Maryland, operating state-of-the-art cultivation facilities and dispensaries. Marimed Inc has also formed strategic partnerships, collaborating with renowned brands like Tikun Olam to bring innovative product offerings to consumers. Additionally, the company's consistent revenue growth and ability to generate positive cash flow further underline its success. Marimed Inc continues to elevate its position as a reputable player in the cannabis sector, showcasing its commitment to long-term growth and shareholder value.

Marimed Inc is primarily present in the United States. As a leading multi-state cannabis operator, Marimed Inc has a significant presence in various states across the nation. With a focus on providing innovative solutions and industry-leading expertise, the company has established itself as a major player in the American cannabis industry. Marimed Inc's operations span multiple regions, including states such as Massachusetts, Illinois, and Maryland. With a strong presence in the United States, Marimed Inc continues to grow and expand its footprint within the rapidly evolving cannabis market.

Marimed Inc represents values of innovation, excellence, and integrity in the cannabis industry. With an emphasis on providing high-quality products and services, Marimed strives to be a leader in the market. The company's corporate philosophy revolves around a customer-centric approach, ensuring that the needs and satisfaction of their clients are always prioritized. Marimed focuses on continuous research and development, enhancing their offerings and staying ahead of the curve in an ever-evolving industry. By combining cutting-edge technology and sustainable practices, Marimed aims to establish a strong presence as a trusted and reliable provider in the cannabis market.

Analysts currently set an average price target of 0.17 USD for the MariMed stock (median: 0.17 USD), implying +151.2 % versus the latest price. The consensus is based on 9 analyst ratings.

MariMed Analyst Price Targets 2026

9 analysts currently rate the MariMed stock: 7 recommend buying, 2 holding and 0 selling. For 2026, analysts expect MariMed to generate revenue of 161.00 M USD and earnings per share of -0.63 USD.

MariMed Analyst Price Targets 2026

Converted at the current exchange rate, the MariMed share trades at 0.06 EUR (0.06 USD).

MariMed Inc. is a company in the cannabis industry that focuses on the development, operation, and financing of specialized cultivation methods and manufacturing facilities. The article describes the business model of MariMed Inc. in detail. MariMed Inc. has focused on four main business areas: MariMed Advisors, MariMed Hemp, Kalm Fusion, and Nature's Heritage. Each of these business areas has its own products, services, and target audiences. The MariMed Advisors business area offers consulting services and support for the establishment and management of cannabis companies. The company assists its clients in all areas of the cannabis industry, from cultivation and processing licensing to product manufacturing and retail operation. MariMed Advisors has a track record of success in launching innovative and successful cannabis companies. MariMed Hemp is an agricultural company specializing in the cultivation of high-quality hemp. The company operates in multiple states in the USA and offers a wide range of hemp products, including oils, capsules, ointments, and tinctures. MariMed Hemp is committed to growing only the finest hemp strains that are sustainably and environmentally friendly. Kalm Fusion is a line of cannabis-infused beverages specifically developed for medical use. The beverages are infused with THC and CBD and help alleviate pain, anxiety, and depression. Kalm Fusion is a significant brand in the emerging cannabis-infused beverages industry and has a growing following of medical cannabis patients. Nature's Heritage is a brand of MariMed Inc. that focuses on the production and distribution of award-winning cannabis products. The products are available in multiple states and have received numerous awards. Nature's Heritage has a reputation for producing high-quality, organic cannabis products that are appreciated by patients and customers alike. MariMed Inc. also offers services such as operation and management of cannabis cultivation facilities, logistics, marketing, and more. Thanks to its wide range of products and services, MariMed Inc. has become a leading company in the cannabis industry. Overall, MariMed Inc. has a diverse business model that focuses on various areas of the cannabis industry. The company has a strong brand presence and a successful track record in supporting cannabis companies as well as manufacturing and selling high-quality cannabis products.

The expected revenue of MariMed is 161.00 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of MariMed is -18.96 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of MariMed is currently -0.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the MariMed stock.

The price-to-sales ratio (P/S) of MariMed is currently 0.01. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the MariMed stock.

The Eulerpool Quality Score for MariMed is 3/10.

The ISIN of MariMed is US56782V1070. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of MariMed is A2DRQF. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of MariMed is MRMD. The ticker symbol is used to trade MariMed shares on the stock exchange.

MariMed paid dividends every year for the past 0 years.

MariMed is assigned to the 'Industry' sector.

The dividends of MariMed are distributed in USD.